Odds of complication in ECM-treated patients demonstrated greater sensitivity to T vs B cell phenotypes, with T cell immunodeficiencies being associated with lower odds of fever, ESR/CRP elevation, dehiscence, bleeding, mortality, tissue ischemia, and hematoma. This evidence concerns the gene CRP and Immunodeficiency.